Meet Portia Combow, who has battled Hidradenitis Suppurativa (HS) for nearly two decades. Portia has been generous enough to share her experiences around the stigma, her long journey to diagnosis, as well as her own discovery of disease management strategies. At Thalocan we work to improve the process of disease assessment in clinical research, the patient experience informs all…
DetailsTo effectively address challenges in clinical trial endpoint management within the immuno-dermatology therapeutic area, a strong team is essential. We are proud to introduce the talented and driven individuals who make up Thalocan Research Innovations. Their expertise and dedication help our customers capture meaningful data to identify treatments that improve patients’ quality of life.
Validating new clinical scales is essential for ensuring data quality and consistent rater assessments. However, the process is often costly, complex, and too critical to leave to chance. Sponsors and research organizations need a reliable Consensus process. Scale development projects are too often abandoned due to timeline and budget constraints. To solve this, Thalocan has…
DetailsWe work hard to be true partners to our clients and collaborators by making their problems our problems. We’re proud of the impact we’ve made and even more honored when our partners share their experiences. Here are a few generous people who took the time to share their experiences with us. We’re grateful for the trust, collaboration,…
DetailsWe’re excited to announce the line-up for our Start Up Showcase, taking place at the Health Equity Congress, May 5 through 7 in Atlanta…
Introducing Thalocan’s new SALT (Severity of Alopecia Tool) training: Best-in-class assessment training for Alopecia Studies…
Looking forward to the program at the Health Equity Congress 2025! The topic is so important in clinical care as well as across the clinical research space. Thank you Kisaco Research!UPDATE: Check out our HEC webinar here.
We have had extraordinary luck in assembling the team we have here at Thalocan. The streak continues today as we welcome @TeresaDeHaemer to the team, I had the pleasure of working with Teresa in my previous life and was impressed by her dedication to clients and her integrity…
The Diversity in Dermatology Conference is definitely worth attending. It was a truly enlightening experience with a variety of perspectives from a broad cohort of healthcare professionals. All in attendance seemed to share a sincere commitment to advancing diversity in all its forms across the field of dermatology. hashtag#DID2025
Thalocan’s Expert-Led QMG Training raises the standard for Myasthenia Gravis assessment instruction. Support your clinicians with detailed guidance in scoring patients on the Qualitative Myasthenia Gravis (QMG). Expert-led by seasoned clinician Laura Herbelin, based on over 30 years of experience in administering MG outcome measures…
Details
